Eli Lilly’s experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant reductions in weight loss and blood sugar levels.
About the Author
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
